Switch to:
More From Other Websites
Medivation: Three Biotech Giants Enter. Which One Leaves? May 25 2016
Sanofi Moves To Replace Medivation’s Board As New Buyers Rumored May 25 2016
Celgene, JNJ, Takeda to Drive Myeloma Drug Sales May 25 2016
Celgene, Gilead Said to Join Suitors Mulling Medivation Bids May 25 2016
Short Sellers Grow More Selective on Major Biotechs May 25 2016
Celgene Corp. breached its 50 day moving average in a Bullish Manner : CELG-US : May 25, 2016 May 25 2016
Biotech: The Next Pricing Controversy? May 23 2016
J&J is Worth as Much as Gilead, Biogen, Mylan, Celgene and Teva Combined. It's Time to Sell. May 20 2016
Celgene Corporation to Webcast at Upcoming Investor Conferences May 20 2016
Celgene Corporation to Webcast at Upcoming Investor Conferences May 20 2016
The top 5 stocks of the past 10 years May 19 2016
Celgene Announces Presentations of Investigational Studies in Solid Tumor and Blood Cancers at ASCO... May 18 2016
How Revlimid’s Label Expansion Could Boost Celgene’s 2016 Revenue May 18 2016
Celgene Announces Presentations of Investigational Studies in Solid Tumor and Blood Cancers at ASCO... May 18 2016
Agios shopped new cancer research program around before partnering with Celgene May 18 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK